FDA Clearance Tracker · K260962
Sphincterotome
Last checked: Nov 19, 2026Latest source record: May 21, 2026 (this decision)Source: openFDAMethods & limitations
Decided
May 21, 2026
Substantially Equivalent
Time to decision
59 days
Received Mar 23, 2026. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K260962
- Device name
- Sphincterotome
- Applicant
- Taewoong Medical Co., Ltd.
- Applicant location
- Gimpo-Si, KR
- Received
- Mar 23, 2026
- Decided
- May 21, 2026
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device class
- Class II
- Regulation
- 21 CFR 876.4300
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code KNS. The earliest in FDA's data is K760178, decided Oct 15, 1976.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K260962
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Taewoong Medical Co., Ltd.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- Niti-S SPAXUS Stent510(k)
K252648 · Decided Mar 13, 2026 · 204 days after receipt
Device type: Pancreatic Stent, Covered, Metallic, Removable (PCU) · GI, Urology & Nephrology
K251123 · Decided Dec 29, 2025 · 262 days after receipt
Device type: Stents, Drains And Dilators For The Biliary Ducts (FGE) · GI, Urology & Nephrology
K243619 · Decided Oct 30, 2025 · 342 days after receipt
Device type: Prosthesis, Esophageal (ESW) · General & Plastic Surgery
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.